Nutra Pharma Corp Stock Analysis

Nutra Pink Sheet Analysis Notes

The company had not issued any dividends in recent years. Nutra Pharma Corp had 1:40 split on the 18th of May 2015. Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.The quote for Nutra Pharma Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Nutra Pharma Corp contact Erik Deitsch at 954 509 0911 or learn more at https://www.nutrapharma.com.

Nutra Pharma Corp Investment Alerts

Nutra Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 759.68 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nutra Pharma's market, we take the total number of its shares issued and multiply it by Nutra Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Nutra Profitablity

The company has Profit Margin (PM) of 28.71 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (5.58) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $5.58.

Technical Drivers

As of the 12th of December 2024, Nutra Pharma secures the Standard Deviation of 15.11, mean deviation of 4.45, and Risk Adjusted Performance of 0.0819. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nutra Pharma Corp, as well as the relationship between them.

Nutra Pharma Corp Price Movement Analysis

Nutra Pharma Outstanding Bonds

Nutra Pharma Technical and Predictive Indicators

Nutra Pharma Forecast Models

Nutra Pharma's time-series forecasting models are one of many Nutra Pharma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nutra Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Nutra Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nutra shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Nutra Pharma. By using and applying Nutra Pink Sheet analysis, traders can create a robust methodology for identifying Nutra entry and exit points for their positions.

When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.